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Aneﬃcientandenvironmentallyfriendlysamplepreparationmethodbasedontheapplicationofhydrophobic1-Hexylpyridinium
hexaﬂuorophosphate [Hpy][PF6] ionic liquid (IL) as a microextraction solvent was proposed to preconcentrate terazosin. The
performance of the microextraction method was improved by introducing a common ion of pyridinium IL into the sample
solution. Due to the presence of the common ion, the solubility of IL signiﬁcantly decreased. As a result, the phase separation
successfully occurred even at high ionic strength, and the volume of the settled IL-phase was not inﬂuenced by variations in
the ionic strength (up to 30%w/v). After preconcentration step, the enriched phase was introduced to the spectroﬂuorimeter
for the determination of terazosin. The obtained results revealed that this system did not suﬀer from the limitations of that in
conventional ionic-liquid microextraction. Under optimum experimental conditions, the proposed method provided a limit of
detection (LOD) of 0.027μgL −1 and a relative standard deviation (R.S.D.) of 2.4%. The present method was successfully applied
to terazosin determination in actual pharmaceutical formulations and biological samples. Considering the large variety of ionic
liquids, the proposed microextraction method earns many merits, and will present a wide application in the future.
1.Introduction
Terazosin is a selective potent α1 adreno-receptor antagonist.
It is an eﬀective drug for hypertension and benign prostatic
hyperplasia [1, 2]. The needs of monitoring trace levels
of terazosin in treated patients with initiate or chronic
treatment routine in chronic regimen, especially in renal
impairment cases, are necessary. To prevent excess employed
dosage, it is critical to develop the sensitive and accurate
techniques for its quantitative analysis. Several analytical
methods have been developed for the measurement of
terazosin in bulk, pharmaceuticals, or biological ﬂuids [3–8].
Sample preparation is a critical step to isolate the
analytes of interest from the sample matrix as well as
to increase the concentration of analytes prior to their
determination, especially when their levels are lower than
the detection limit of analytical techniques. Liquid-liquid
extraction (LLE) and solid-phase extraction (SPE) have been
widely used as basic, simple, and adaptable methods for
sample preconcentration. However, some drawbacks such
as the use of large amount of hazardous organic solvents,
and the employment of multistep procedures associated with
the high risk of analyte losses make LLE and SPE tedious,
expensive, and environmentally unfriendly. In recent years,
reduction or complete removal of hazardous organic sol-
vents in sample pretreatment techniques has received great
attention. For this goal, many microextraction methods such
as dispersive liquid-liquid microextraction (DLLME) [9–
12], single-drop microextraction (SDME) [13–15], stir bar
sorptive extraction [16], and so forth, have been developed
to reduce the amount of toxic solvents. In some of these
procedures, however, the use of toxic materials like benzene,2 International Journal of Analytical Chemistry
toluene, or chloroform as the microextraction solvent is a
common practice.
Ionic liquids (ILs) are ionic media resulting from
combinations of organic cations and diﬀerent anions. ILs
have a variety of chemical and physical properties such as
low vapor pressure, excellent thermal stabilities, adjustable
miscibility, moderate solubility of organic compounds and
metal ions, and so forth, which make them highly attractive
in microextraction methods [17]. ILs have been widely
applied in many sample pretreatment procedures as green
extraction solvent including ionic liquid-based liquid-liquid
microextraction (IL-LLME) [18, 19], cold induced aggre-
gation microextraction (CIAME) [20], ionic liquid-based
single-drop microextraction (IL-SDME) [21, 22], ionic
liquid-based dispersive liquid-liquid microextraction (IL-
DLLME) [23, 24], in situ solvent formation microextraction
(ISFME)[25],temperature-controlledionicliquiddispersive
liquid phase microextraction (TILDLME) [26], and so forth.
The use of separation and preconcentration steps based
on IL-based microextraction methods oﬀers several advan-
tages such as high recovery, no need of hazardous extraction
solvent,simplicityofoperation,andcompatibilitywithmany
analytical techniques. Despite the many advantages of using
ionic liquid-based microextraction techniques, under high
salt condition, the ﬁne droplets of the extraction phase can
not be settled due to increase in sample solution density.
The solubility of ionic liquids increases as the salt amount of
sample increases. As a result, the volume of the settled phase
depends signiﬁcantly on the ionic strength of the sample
solution. On the other hand, accuracy and performance
of the extraction method are signiﬁcantly inﬂuenced by
variationsintheionicstrength.Inthiswork,inordertosolve
these problems and obtain higher accuracy, a novel, simple,
and powerful ionic-liquid microextraction method which
put very few dangers to environment was developed. In the
proposed approach, a hydrophobic pyridinium IL was added
totheaqueoussamplesolutioncontainingoneoftheIL’sions
asacommoniontoactastheextractionphase.Hydrophobic
1-hexylpyridinium hexaﬂuorophosphate [Hpy][PF6] ionic
liquid and NaPF6 were used as the extraction phase and
common ion source, respectively. Due to the presence of the
common ion in the sample, the solubility of IL decreases,
even at high ionic strength. Therefore, the volume of the
enriched phase is independent from the ionic strength.
In this work, [Hpy][PF6] was employed as the extractant
solvent due to some physicochemical properties such as high
hydrophobicity, water immiscibility, and suitable density.
Thepresentmethodologydoesnotneedheating,antisticking
agent, long equilibration time, and cooling before or after
centrifugationpriortoanalysis.Tothebestofourknowledge,
up until now, no method based on the microextraction with
ILs and spectroﬂuorimetric detection has been proposed for
preconcentration, extraction, and determination of drugs in
their trace levels. Spectroﬂuorimetric method was applied
due to ease, proper selectivity, sensitivity, wide dynamic
range, and low cost of operation. The goal of this paper is
to study the applicability of the proposed microextraction
method followed by spectroﬂuorimetry to determine tera-
zosinasamodelcompoundinpharmaceuticalandbiological
samples. Furthermore, the obtained results reveal that the
proposedmethodologyissimpleandpracticalfortheroutine
determination of terazosin in aqueous media.
2. Experimental
2.1. Instrumentation. Fluorescence measurements were per-
formed using a Perkin-Elmer LS 50 spectroﬂuorimeter
equipped with xenon discharge lamp, and quartz micro-
cell with a volume of 100μL. A centrifuge from Hettich
(Tuttlingen, Germany) was utilized to accelerate the phase
separation process. An adjustable sampler (10–100μL) was
prepared from Eppendorf (Hamburg, Germany). The pH-
meter model 692 (Herisau, Switzerland) supplied with a
glass-combined electrode and universal pH indicator (pH 0–
14) from Merck (Darmstadt, Germany) were used for the pH
measurements.
2.2. Reagents and Materials. All chemicals used were of
analytical reagent grade and all solutions were prepared with
ultrapure water. 1-Hexylpyridinium hexaﬂuorophosphate
[Hpy][PF6] (97%) (Acros organics, Belgium) was applied
as an extractant solvent. Acetone, acetonitrile, methanol,
ethanolandsodiumhexaﬂuorophosphate(NaPF6)werepur -
chased from Merck (Darmstadt, Germany). Stock solution
of terazosin at concentration of 1000mgL−1 was prepared
by dissolving the required amount of pure drug in ultrapure
water, and working standard solutions were obtained by
serial dilutions of this stock solution. [HPy][PF6]I Li sn o t
liquidatroomtemperature(meltingpoint:45◦C).Therefore,
this IL was dissolved in acetonitrile to obtain a working
solution of 75mgmL−1. A solution of 250mgmL−1 NaPF6
was obtained by dissolving appropriate amount of this salt
in ultrapure water. 0.5molL−1 of sodium hydroxide and
concentrated hydrochloric acid were used for adjusting the
pH value of sample solutions. Terazosin tablets (labeled as
containing 2 and 5mg terazosin per tablet) were obtained
from Daroupakhsh (Iran, Tehtan).
2.3. General Analytical Procedure. Aliquots of 10.0mL sam-
ple or standard solution (pH 10) containing terazosin in
the range of 0.1 to 115μgL −1 w a sp l a c e di n t oag l a s st e s t
tube with conic bottom, 1.4mL of NaPF6 (250mgmL−1)
was added. Then, 150mg of [HPy][PF6] (dissolved in ace-
tonitrile) as the extraction solvent was added to the sample
solution. After shaking, a cloudy condition was immediately
formed at room temperature. Due to the formation a large
contact area between extraction solvent and analyte, the
uncharged form of terazosin was rapidly trapped into IL-
phase. In order to accelerate phase separation, the resultant
solution was centrifuged for 5min at 4000rpm. The upper
aqueous solution was then removed by a pipette. Finally, in
ordertoreducetheviscosityofIL-phaseandfacilitatesample
handling prior to analysis, the settled phase (about 16μL)
in the test tube was diluted to 250μL by adding appropriate
amount of ethanol. 100μL of the diluted settled phase was
removed by a sampler and transferred to the microcell of
the ﬂuorimeter. The ﬂuorescence intensity was measuredInternational Journal of Analytical Chemistry 3
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Figure 1: (a) Emission spectra obtained for 8 standard solutions of terazosin with diﬀerent concentrations. (b) Emission spectrum of
terazosin (75μgL −1) treated the same as previously described in the general analytical procedure (a), and emission spectrum of reagent
blank in [Hpy][PF6] ionic liquid (b). Inset: chemical structure of [Hpy][PF6] ionic liquid. Experimental conditions were as indicated in the
Table 1.
at 376nm with the excitation wavelength set at 330nm. A
reagent blank was prepared using a similar procedure but
without adding terazosin.
2.4. Analysis of Tablets. Five terazosin tablets, labeled as con-
taining 2mg terazosin each, were weighed and the average
mass per tablet was determined. An amount of the powder
equivalent to 2mg of terazosin was accurately weighed
and dissolved in 50mL ultrapure water. The solution was
sonicated for 5min and ﬁltered into a 100mL volumet-
ric ﬂask. Further dilutions were made up with ultrapure
water to achieve a ﬁnal concentration of 20μgmL −1.I n
addition, appropriate dilution was performed for terazosin
analysis.
2.5. Analysis of Spiked Human Plasma. Human plasma
samples (1.0mL) were spiked with terazosin solutions, de-
proteinized by adding 4mL acetonitrile, and centrifuged at
4000rpm for 15min. Then, 2.0mL of the clear supernatant
was diluted to 50mL and subjected to the proposed method.
2.6. Analysis of Spiked Human Urine. Fresh matutinal hu-
man urine (10mL) was transferred into graduated cen-
trifuge tubes. These solutions were centrifuged for 5min at
4000rpm. Then, aliquots of 2mL from clear supernatant
were put in new centrifuge tubes and spiked with diﬀerent
amounts of terazosin (2 to 100μgL −1); the general analytical
procedure was followed.
3. Results and Discussion
Inthiswork,apracticalandsimpleionic-liquidmicroextrac-
tion method was combined with spectroﬂuorimetry for pre-
concentration and determination of terazosin. Hydrophobic
[Hpy][PF6] and NaPF6 were applied as the extraction phase
and common ion source, respectively. In the proposed
microextraction method, the volume of the enriched phase
was independent form the ionic strength of the sample
solution (up to 30% w/v) which as an advantage signiﬁcantly
improved the performance of the extraction method. The
inﬂuence of diﬀerent factors aﬀecting extraction conditions
werestudiedandoptimized toobtainacompromisebetween
sensitivity, simplicity, and reproducibility.
3.1.SpectralCharacteristicsofTerazosinand[HPy][PF6]. The
intense ﬂuorescence of terazosin is due to its cyclic conju-
gated structure which beneﬁts of having π-electron system.
The emission spectra of terazosin were recorded as described
in the general analytical procedure (see Figure 1(a)). As it
can be ascertained, the emission peak of terazosin is at
376nm, while its excitation peak is at 330nm. In order
to obtain accurate ﬂuorescence intensity, it is important
to study the eﬀect of the extraction phase on ﬂuorescence
spectrumoftheanalyteofinterest.Forthisgoal,ﬂuorescence
spectrum of the reagent blank was evaluated. As it can be
seen in Figure 1(b), the emission of [HPy][PF6]h a sn o
notable eﬀect on the determination of terazosin. Thus, the
aforementioned wavelengths were selected for quantitative
analysis of terazosin.4 International Journal of Analytical Chemistry
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Figure 2: Inﬂuence of amount of [Hpy][PF6] on the ﬂuores-
cence intensities. Experimental conditions: terazosin concentration
75μgL −1; pH 10; NaPF6 350mg.
3.2. Inﬂuence of IL Amount. The amount of [HPy][PF6]i s
a critical parameter which can aﬀect the analyte recoveries.
Thus, the microextraction procedure was carefully evaluated
in order to achieve a compromise between the amount of
IL and the analytical responses. The Eﬀect of [HPy][PF6]
amount on the analytical responses was studied within the
range of 25–400mg. Figure 2 shows the variation of the
ﬂuorescence signal versus the amount of [HPy][PF6]. As
it can be ascertained, the signal intensity increases as the
amountof[HPy][PF6]increasesandremainsnearlyconstant
from 125mg. No signiﬁcant variations were obtained on the
microextraction eﬃciency for higher amounts of IL. Thus, in
order to achieve sensitive analytical response, 150mg of IL
was selected as an optimum value.
3.3. Inﬂuence of Common Ion. The eﬀect of NaPF6 amount
as a common ion source on the ﬂuorescence signal was
studied within the range of 0–400mg (see Figure 3). Due
to the common ion inﬂuence, an increase in the amount
of NaPF6 causes a notable decrease in the solubility of
[HPy][PF6]. As a result, the extraction performance and the
analytical intensity increase. As it can be seen in Figure 3, the
ﬂuorescence intensity increases with increasing the amount
of NaPF6 up to 325mg and then remains nearly stable.
However, 350mg of NaPF6 was chosen through the rest of
the work.
3.4. Inﬂuence of Diluting Agent. Due to the high viscosity of
the IL, it must be conditioned with a diluting agent prior
to its introduction to the spectroﬂuorimeter. Several diluting
agentsincludingmethanol,ethanol,acetone,andacetonitrile
were evaluated in order to choice a diluting agent which
can dissolve the IL-phase completely and provide the best
sensitivity. Type of the organic solvent had no signiﬁcant
eﬀect on the analytical response. Finally, due to less toxicity
of ethanol, it was applied as diluting agent in all experiments.
3.5. Inﬂuence of pH. The pH of the sample is an important
factor which aﬀects the chemical structure of terazosin. The
eﬀect of pH on the extraction of terazosin from aqueous
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Figure 3: Inﬂuence of NaPF6 on the analytical signals obtained
for terazosin. Experimental conditions: terazosin concentration
75μgL −1; pH 10; [Hpy][PF6] 150mg.
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Figure 4: Inﬂuence of pH on the ﬂuorescence intensities. Exper-
imental conditions: terazosin concentration 75μgL −1; [Hpy][PF6]
150mg; NaPF6 350mg. Inset: chemical structure of terazosin. Acid
base equilibrium involved at working pH. (a) Protonated form of
this terazosin; (b) dissociated form of terazosin.
samples was studied over the range of 5–12 using HCl
and NaOH. For ionizable organic molecules, maximum
extraction eﬃciency is obtained at pH values where the
uncharged form of the analyte overcomes, and therefore,
the analyte of interest is favored to be partitioned into the
hydrophobic IL-phase. The results illustrated in Figure 4
reveal that analytical signals, obtained for terazosin, depend
on pH. The best conditions of terazosin microextraction
were achieved at alkaline pH values due to dissociation of
the aromatic amine group, which acts as a weak base (see
Figure 4)( p K b = 6.9). Based on the results obtained, pH 10
was selected as the optimum value.
3.6. Inﬂuence of Equilibration Temperature and Extraction
Time. In order to obtain complete extraction of terazosin
and easy phase separation, the eﬀect of equilibration tem-
perature was studied from 5 to 40◦C. Based on the results
obtained in this study, the temperature had no signiﬁcant
and beneﬁc eﬀect on the extraction eﬃciency. Therefore,
r o o mt e m p e r a t u r ea sa ne q u i l i b r a t i o nt e m p e r a t u r ew a sInternational Journal of Analytical Chemistry 5
used through the rest of the work. Microextraction time
is one of the important factors aﬀecting the extraction
eﬃciency, especially in microextraction methods such as
SPME and LPME. The dependence of extraction eﬃciency
upon extraction time was studied from 5sec to 30min.
The results obtained in this experiment revealed that signal
variations versus extraction time were not signiﬁcant. It was
demonstrated that after formation of the cloudy condition,
thesurfaceareabetweenextractionphaseandaqueousmedia
was inﬁnitely large. Thus, the transfer of the target analyte
from aqueous media to IL-phase was very fast. In order to
keep extraction time as short as possible, the cloudy solution
was centrifuged immediately after the preparation.
3.7. Inﬂuence of Centrifugation Condition. The eﬀect of cen-
trifugation rate on the ﬂuorescence intensity was evaluated
from 1000 to 6000rpm. The obtained results showed that
over3500rpmtheIL-phasewascompletelytransferredtothe
bottomofthetesttube,andtheanalyticalresponseremained
constant. Thus, 4000rpm was selected for all experiments.
At the optimum rate, the eﬀect of centrifugation time upon
analytical responses was investigated within the range of
1–15min. Over 4min, the ﬂuorescence intensity remained
stable indicating entire transfer of IL-phase to the bottom of
thecentrifugetube.Therefore,acentrifugationtimeof5min
was chosen as the optimum value.
3.8. Inﬂuence of Salt Concentration. Inﬂuence of salt concen-
tration on the extraction performance was studied by adding
various amounts of NaNO3 from 0 to 40% (w/v) while other
experimental conditions were kept constant. In the proposed
microextraction method, due to the presence of PF6
− as
a common ion in the sample solution, the volume of the
enrichedphasewasindependentfromtheionicstrength,and
phase separation occurred up to 30% w/v of NaNO3. Table 1
summarizes both instrumental and experimental conditions
selected.
3.9. Inﬂuence of Interfering Substances. The eﬀect of diﬀerent
chemical species on the determination of target analyte was
studied using solutions containing 75μgL −1of terazosin, and
adding 100mgL−1 of the possible interfering species. The
tolerance limit of each interfering substance was taken into
account as the largest amount yields an error in the deter-
mination of the target analyte which does not exceed 5%.
No interference was observed from commonly interfering
s p e c i e ss u c ha sN a +,N H 4
+,C a 2+,Z n 2+,M g 2+,C l −,P O 4
3−,
SO4
2−, starch, glucose, lactose, fructose, sucrose, ascorbic
acid, citric acid, dye species (as yellow quinoline), urea,
and saccharin. The obtained results revealed the excellent
selectivity of the proposed methodology in detecting the
studied drug in dosage form and biological samples.
4. Application
4.1. Analytical Performance. Under the optimum conditions,
calibration graph was achieved by analyzing 10.0mL of
standard solutions containing known amounts of terazosin.
Table 1: The experimental conditions for terazosin determination.
Microextraction parameters Studied
range Selected condition
Amount of NaPF6 (mg) 0–400 350
Amount of [Hpy][BF4] (mg) 25–400 150
pH 5–12 10
Equilibration temperature (◦C) 5–40 Room temperature
Centrifugation time (min) 1–15 5
Ionic strength (% w/v) 0–40 NEa
Instrumental parameters
Excitation wavelength (nm) 200–350 330
Emission wavelength (nm) 350–700 376
Excitation and emission slit
widths (nm) 5–20 10
aNo eﬀect.
Table 2: Determination of terazosin in tablets by the proposed
methodology and by a reported voltammetric method [8].
Claimed
(mg/tablet)
Proposed
methodology
(mg)a
Reported
method
(mg)a
Error (%)b Error (%)c
21 . 9 5 ( ±0.08) 2.07 (±0.10) −2.5 −5.8
55 . 1 ( ±0.21) 5.27 (±0.37) +2.0 −3.2
aValuesinparenthesisshowthestandarddeviationbasedonthreereplicates.
bError against the declared value.
cError against the reported method.
The settled ionic phase was diluted to 250μL with ethanol
andtheﬂuorescenceintensitywasrecorded.Therefore,apre-
concentration factor of 40 was achieved. The enhancement
factor calculated as the slope ratio of calibration graph after
andbeforeextractionwasabout33.Thelinearconcentration
range was from 0.1 to 115μgL −1 of terazosin with linear
regression equation as
I = 51.33 + 7.5608 C,( 1 )
where I is the ﬂuorescence intensity at 376 ± 3nm and
C is the terazosin concentration in μgL −1. The relative
standard deviation (R.S.D.) obtained for the determination
of 75μgL −1 of terazosin was 2.4% (n = 5). The limit
of detection (LOD), calculated as three times the standard
deviation of the measurement of blanks divided by the slope
of the calibration curve, was found to be 0.027μgL −1.
4.2. Analysis of Terazosin in Pharmaceutical Formulations.
In order to show the validity of the proposed method,
it was applied for terazosin determination in commercial
tablets. Three replicate determinations were performed, and
satisfactory results were achieved. Table 2 shows the results
obtained by applying the present method and those obtained
byareportedvoltammetricmethod[8].Untildatenooﬃcial
method has been reported for terazosin determination. The
results show the applicability of the proposed methodology
and its accuracy for quantitative analysis of terazosin in this
type of samples.6 International Journal of Analytical Chemistry
Table 3: Determination of terazosin in spiked urine and spiked plasma by present work.
Drug
Spiked urine Spiked plasma
Amount added
(μgL −1)
Amount found
(μgL −1) ± S.D.a
Recovery
(%)
Amount added
(μgL −1)
Amount found
(μgL −1) ± S.D.a
Recovery
(%)
Terazosin
21 .83 ±0.09 91.5 2 1.73 ±0.11 86.5
54 .81 ±0.28 96.2 5 4.82 ±0.33 96.4
10 9.40 ±0.30 94.0 10 9.60 ±0.51 96.0
100 105.81 ±4.11 105.8 100 93.10 ±4.88 93.1
aAverage of three independent measurements.
Table 4: Comparison of the proposed approach with other reported methods for determination of terazosin.
Method Sample LOD (μgL −1) R.S.D. (%) LR (μgL −1) References
Spectroﬂuorimetry Serum, urine 210 2.5 Up to 3486.9 [4]
X-ray ﬂuorescence spectrometry Drug 732 — 732–843000 [5]
HPLC with ﬂuorescence detection Plasma 0.25 <7 Up to 100 [6]
HPLC with electrospray ionization
mass spectrometry detection Plasma 0.0625 — — [7]
Square-wave adsorptive cathodic
stripping voltammetry Plasma, drug 0.0058 <1.1 0.39–11.62 [8]
ionic-liquid microextraction
spectroﬂuorimetry Urine, plasma, drug 0.027 2.4 0.1–115 This work
LOD: limit of detection, LR: linear range, R.S.D.: relative standard deviation.
4.3. Analysis of Terazosin in Spiked Human Plasma and
Urine. The accuracy of the present method was evaluated
by determination of terazosin in spiked human urine and
spiked human plasma. The recovery of the studied drug was
investigatedatfourconcentrationlevels.Theobtainedresults
are shown in Table 3. As can be seen, calculated amounts
of recoveries varied between 91.5–105.8% and 86.5–96.0%
for human urine and human plasma, respectively, indicating
both accuracy and precision.
4.4. Comparison with Other Reported Methods. Determina-
tion of terazosin by the proposed methodology was com-
pared with other reported techniques. The results are shown
in Table 4. As it can be seen, compared to the previously
reported methods, the present method has a relatively low
LOD, wide dynamic range, and excellent reproducibility. The
method developed in this work is proposed as a suitable
alternative to expensive instrumental methods for trace
determination of terazosin in pharmaceutical and biological
samples. These results reveal that the proposed approach is
a very sensitive, low-cost, rapid, environmentally friendly
and accurate technique that can be used for terazosin
determination in routine analytical laboratories.
5. Conclusion
An o v e la n de ﬃcient mode of ionic-liquid microextrac-
tion was combined with spectroﬂuorimetric detection to
preconcentrate and determine trace levels of terazosin.
Hydrophobic [Hpy][PF6] ionic liquid was applied as a green
extraction solvent and an alternative to hazardous organic
solvents. Due to the presence of one of the IL’s ions as a
common ion in the sample solution, the performance of the
microextraction method was not inﬂuenced by variations
in the ionic strength of the aqueous solution (up to 30%).
The method developed in this work was demonstrated to
be simple, rapid, practical, inexpensive, and environmentally
friendly for preconcentration and separation of the trace
analytes. In addition, the present method revealed to be
a practical tool for routine quality control of drugs in
pharmaceutical and biological samples with low operation
cost and simplicity of instrumentation.
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